A Randomised, Multicentric, Open Labelled, Parallel Group Trial With Insulin Aspart and Insulin Detemir, Investigating the Glycaemic Effect and Profile in Children With Type 1 Diabetes, of Two Separate Levemir + NovoRapid Injections and Extemporaneous Mixing - The Paediatric MIXING Trial.
Latest Information Update: 01 Apr 2022
At a glance
- Drugs Insulin aspart (Primary) ; Insulin detemir (Primary)
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms MIXING
- Sponsors Novo Nordisk
- 13 Mar 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 13 Mar 2009 Actual patient number (25) added as reported by ClinicalTrials.gov.
- 02 Mar 2009 Planned end date changed from Feb 2009 to Mar 2009 as reported by ClinicalTrials.gov.